China Vanke : THE INDICATIVE ANNOUNCEMENT REGARDING H SHAREHOLDERS' COMPLIANCE WITH EPIDEM...

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this notice, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this notice.

CHINA VANKE CO., LTD.*

萬科企業股份有限公司

(A joint stock company incorporated in the People's Republic of China with limited liability)

(Stock Code: 2202)

THE INDICATIVE ANNOUNCEMENT REGARDING H SHAREHOLDERS'

COMPLIANCE WITH EPIDEMIC PREVENTION ARRANGEMENTS

TO ATTEND THE 2021 FIRST EXTRAORDINARY GENERAL MEETING

AND THE SECOND H SHAREHOLDERS CLASS MEETING OF 2021

References are made to the notice, the circular and the respective forms of proxy of extraordinary general meeting (the "Form of Proxy for the EGM") and H shareholders class meeting (the "Form of Proxy for H shareholders Class Meeting") of China Vanke Co., Ltd. (the "Company") dated 10 November 2021 in relation to the 2021 first extraordinary general meeting (the "EGM") and the second H shareholders class meeting of 2021 (the "H Shareholders Class Meeting", collectively with the "EGM", the "Meetings") (the abovementioned documents collectively called "Series Announcements of the Meetings"). Unless the context otherwise requires, the terms used in this announcement shall have the same meanings as defined in the Series Announcements of the Meetings.

In view of current status of epidemic prevention and control requirements, the Company shall remind matters regard attending Meetings which need attention of H Shareholders again. Other contents in the Series Announcements of the Meetings remain unchanged.

1. H SHAREHOLDERS ARE RECOMMENDED TO ATTEND THE MEETINGS BY PROXY
   In view of the severe and complicated situation of the COVID-19 pandemic prevention and control, the Company recommends H Shareholders to fill in and submit the Form of Proxy for the EGM and Form of Proxy for H shareholders Class Meeting (the "Proxy Forms"), appointing the chairman of the Meetings or other persons as proxies to attend the Meetings and exercise voting rights as instructed in the Proxy Forms. H Shareholders who wish to attend the Meetings in person are required to observe the following epidemic prevention arrangements.

1

1. EPIDEMIC PREVENTION ARRANGEMENTS TO BE COMPLIED WITH BY H SHAREHOLDERS WHO WISH TO ATTEND THE ON-SITE MEETINGS
2. 1. Register in advance
      Based on the epidemic prevention and control requirements of the relevant local government departments of the Meetings, H shareholders who wish to attend the Meetings shall call the Company (see below for specific contact numbers) at least 24 hours prior to the convening of the Meetings to consult and confirm.
   2. Strictly comply with the epidemic prevention and control requirements at the venue of the Meetings
      The Company will take measures for prevention and control of the epidemic, such as registration for the meeting, monitoring body temperature, and checking health code, telecommunication data based travel itinerary card and negative nucleic acid test report within 48 hours prior to the convening of the Meetings, for Shareholders or proxies attending the Meetings on site.
   3. Circumstances under which H Shareholders cannot enter the venue of the Meetings
      H Shareholders or shareholders' proxy, after consult and confirm with the Company, will not be able to enter the venue of the Meetings under any of the following circumstances:
   4. 1. he/she fails to provide a negative nucleic acid test report within 48 hours prior to the convening of the Meetings;
      2. his/her health code is in yellow or red colour;
      3. his/her telecommunication data based travel itinerary card shows that the city or cities that he/she has arrived or passed through within 14 days prior to the convening of the Meetings with an "*" symbol;
      4. he/she exhibits symptoms such as fever and cough;
      5. he/she does not wear masks as required;
      6. he/she fails to comply with the rules and requirements in relation to epidemic prevention and control.

2

1. CONTACT
   For any inquiries regarding attending the Meetings, please contact the following before 25 November 2021:
   Telephone: +86(755)2560 6666 transfer to Board Office
   Fax:+86(755)2553 1696 (please indicate "transfer to Board Office" on the fax)
   Email:IR@vanke.com

Address: Vanke Center, No. 33 Huanmei Road, Dameisha, Yantian District,

Shenzhen, the People's Republic of China

By order of the Board

China Vanke Co., Ltd.*

Zhu Xu

Company Secretary

Shenzhen, the PRC, 19 November 2021

As at the date of this announcement, the Board comprises Mr. YU Liang, Mr. ZHU Jiusheng and Mr. WANG Haiwu as executive directors; Mr. XIN Jie, Mr. HU Guobin and Mr. Huang Liping as non- executive directors; and Mr. KANG Dian, Ms. LIU Shuwei, Mr. NG Kar Ling, Johnny and Mr. ZHANG Yichen as independent non-executive directors.

• For identification purpose only

3